Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120,517 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213).
Jin ZC, Zhou JW, Chen JJ, Ding R, Scheiner B, Wang SN, Li HL, Shen QX, Lu QY, Liu Y, Zhang WH, Luo B, Shi HB, Huang M, Wu YM, Yuan CW, Huang MS, Li JP, Wu JB, Zhu XL, Zhong BY, Zhou HF, Wang YQ, Gu SZ, Peng ZY, Zheng CS, Liu RB, Xu GH, Yang WZ, Xu AB, Liu DF, Qi X, Yeo YH, Zhu HD, Zhao Y, Pinato DJ, Ji F, Teng GJ. Jin ZC, et al. Among authors: li hl. J Cachexia Sarcopenia Muscle. 2024 Nov 27. doi: 10.1002/jcsm.13615. Online ahead of print. J Cachexia Sarcopenia Muscle. 2024. PMID: 39604073
Corrigendum to "Single-cell RNA sequencing reveals heterogeneity in ovarian cancer and constructs a prognostic signature for prognostic prediction and immunotherapy" [Int. Immunopharmacol. 140 (2024) 112855].
Zhou S, Li H, Zhao C, Zhao W, Pan X, Jian W, Wang J. Zhou S, et al. Among authors: li h. Int Immunopharmacol. 2024 Nov 26:113489. doi: 10.1016/j.intimp.2024.113489. Online ahead of print. Int Immunopharmacol. 2024. PMID: 39603953 No abstract available.
Corrigendum to "Quercetin inhibits mitophagy-mediated apoptosis and inflammatory response by targeting the PPARγ/PGC-1α/NF-κB axis to improve acute liver failure" [Int. Immunopharmacol. 143P2 (2024) 113444].
Wu H, Wu L, Luo L, Wu YT, Zhang QX, Li HY, Zhang BF. Wu H, et al. Among authors: li hy. Int Immunopharmacol. 2024 Nov 26:113679. doi: 10.1016/j.intimp.2024.113679. Online ahead of print. Int Immunopharmacol. 2024. PMID: 39603952 No abstract available.
120,517 results
You have reached the last available page of results. Please see the User Guide for more information.